Cart
sales@molnova.com
N-(4-fluorophenyl)benzo[d]thiazol-2-amine
CAS No. 348-45-8
N-(4-fluorophenyl)benzo[d]thiazol-2-amine( —— )
Catalog No. M28897 CAS No. 348-45-8
N-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 107 | Get Quote |
|
| 10MG | 177 | Get Quote |
|
| 25MG | 374 | Get Quote |
|
| 50MG | 531 | Get Quote |
|
| 100MG | 770 | Get Quote |
|
| 500MG | 1521 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameN-(4-fluorophenyl)benzo[d]thiazol-2-amine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
-
DescriptionN-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCYP17
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number348-45-8
-
Formula Weight244.29
-
Molecular FormulaC13H9FN2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (511.69 mM)
-
SMILESFc1ccc(Nc2nc3ccccc3s2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang M, et al. Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors. Eur J Med Chem. 2017 May 26;132:157-172.
molnova catalog
related products
-
AT-56
AT56, a specific inhibitor of prostaglandin D2 synthase enzymatic activity, blunted adipogenic aldosterone effects.
-
Harmidol hydrochlori...
Harmalol hydrochloride is a β-carboline alkaloid that can be extracted from the seeds of Peganum harmala L. Harmalol hydrochloride is the major metabolite of Harmaline and significantly inhibits dioxin-mediated induction of CYP1A1 at both transcriptional and post-translational levels.
-
Nimacimab
Nimacimab is a recombinant humanized monoclonal antibody. It can improve diabetes and non-alcoholic steatohepatitis.
